United States: Weeks II: Innovator Liability Finds A Sweet Home In Alabama

Last week, the Supreme Court of Alabama confirmed its January 2013 holding that manufacturers of brand drugs can be liable for injuries caused by generic drugs. Weeks v. Wyeth, Inc., No. 1101397, slip op. (Ala. Aug. 15, 2014). Though the recent ruling puts Alabama in a very small minority of jurisdictions recognizing "innovator liability," it still represents a state supreme court holding that exposes brand drug manufacturers to liability they had not previously known. The ruling will likely result in significant new filings by the plaintiffs' bar in Alabama, and renewed arguments by them for other jurisdictions to follow Alabama's reasoning.


The Weeks case was originally decided in January 2013.1 In that opinion, the Alabama court became the first state supreme court to hold that brand drug manufacturers could be liable for injuries caused by generic drugs because the warnings and labels relied on were those of the brand drug. That ruling was contrary to the overwhelming majority of other courts, both trial courts and appellate courts alike who ruled against liability unless the drug ingested was from the brand drug company. The Supreme Court of Alabama was excoriated by many for deciding such an important question without oral argument. When the court decided to rehear the case, this time with oral argument, many in the pharmaceutical industry viewed this as an omen that reversal was likely. As time passed, it was thought the court might be carefully crafting a new opinion.

That hope was misplaced. The new Weeks opinion is surprising and disappointing to the pharmaceutical industry; it essentially re-states the original opinion despite the fact that it had been nearly one year since oral argument and many courts had weighed in on this issue in the intervening year and a half since the first opinion.


Our previous client alert examined the rationale behind the original holding. Essentially, the Supreme Court of Alabama held that it was foreseeable that a generic drug user's doctor would rely on representations by a brand drug manufacturer. In reaching this conclusion, the court relied on PLIVA, Inc. v. Mensing, 131 S. Ct. 2567 (2011), which interpreted federal statutes and regulations as requiring generic drug manufacturers to copy brand drug manufacturers' labels. Unlike most other courts that have examined this issue, theWeeks court found that the foreseeability deriving from the federal regulatory scheme was sufficient to establish that the brand drug manufacturer owed the generic drug user a duty of care.

In reaching this decision once again (Weeks II), the court highlighted Alabama law regarding misrepresentation and "the fact that two parties have had no contractual relationship or other dealings does not preclude the finding of a legal duty not to make a material misrepresentation or to suppress a material fact." The majority concluded its opinion by reiterating that the fraud or misrepresentation claim at issue here premises liability not on "a defect in the product itself but as a result of statements made by the brand-name manufacturer that Congress, through the FDA, has mandated be the same on the generic version of the brand-name drug."


Justice Shaw specially concurred to clarify and defend the majority's opinion. He noted several points. First, the court's holding in no way meant that a company could generally be held liable for products it did not manufacture. Second, the court did not create new law. Instead, it applied existing Alabama law dealing with fraudulent conduct. He found that Alabama case law "generally holds that a duty to disclose may be owed to a person with whom the defendant has had no prior dealings, specifically, where there is a 'duty' not to make a false representation."

Third, the majority opinion is extremely narrow and would not apply outside the pharmaceutical context. This appears to be in direct response to critics who have "either shamefully misrepresented our holding or bordered on the hysterical" in response to the original Weeks opinion. Fourth, "no decision of any other jurisdiction addresses the precise question of Alabama law discussed in our answer."

Finally, Justice Shaw rejected the notion that the decision might stifle business. Instead, the court's decision "epitomizes the kind of judicial restraint that should be expected of an appellate court."


Three justices dissented. Chief Justice Moore felt the court should not have accepted the certified question because the answer was not dispositive of the case in the trial court. Justice Parker felt the court overstepped its authority, especially because he interpreted Mensing and Mutual Pharmaceutical Co. v. Bartlett, 131 S. Ct. 2567 (2013), as making "clear that [a generic drug] consumer is left without a remedy absent a legislative change by Congress."

Justice Murdock passionately dissented, penning an opinion equal in length to that of the majority's. He opened by quoting Alexander Hamilton and invoking the great American "spirit of enterprise" to highlight the injustice that would no doubt result from the court's holding. The dissent's reasoning was twofold. First, every other court (with the exception of Conte v. Wyeth, Inc., 168 Cal. App. 4th 89 (2008) and Kellogg v. Wyeth, Inc., 762 F. Supp. 2d 694 (D. Vt. 2010)) that had evaluated this issue disagreed with this court. Second (not content with the herd mentality argument), Justice Murdock fell back on the tried-and-true premise that this would "stretch the concept of foreseeability too far." Foster v. Am. Home Prods., 29 F.3d 165, 171 (4th Cir. 1994). Justice Murdock's variation on this theme was that foreseeability alone is insufficient to create a duty; in addition to foreseeability there must be a relationship between the two parties.

After conducting an extensive survey of decisions on the issue, Justice Murdock came full circle, predicting the negative impact that the court's holding would have on free enterprise. He worried that brand drug manufacturers would be unable to predict their liability, and this would create an insurability issue. Meanwhile, the court's reasoning could spill over into areas beyond pharmaceuticals and compound the problem.


Justice Murdock's concerns about the court's decision reaching beyond drugs are unnecessarily alarmist, given the unique federal regulatory scheme governing drugs and the stringent requirements that generic drug manufacturers maintain labels identical to those of the brand drug manufacturer's. However, innovator liability is now the law of Alabama and brand drug manufacturers should be concerned that filings there will increase. While choice of law rules may prevent out-of-state plaintiffs from taking advantage of Alabama law, the end result remains to be seen. It also remains to be seen whether the pharmaceutical industry will encourage the Alabama legislature to establish new product liability law to overcome the ruling, rather than face unlimited liability for another company's drugs.


1 See "Weeks Defies Years of Jurisprudence", Morrison and Foerster client alert.

Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Morrison & Foerster LLP. All rights reserved

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Erin M. Bosman
Julie Y. Park
In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement

    Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of www.mondaq.com

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at enquiries@mondaq.com.

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions